miR-22 suppresses cell viability and EMT of ovarian cancer cells via NLRP3 and inhibits PI3K/AKT signaling pathway
Haipeng Wu, Jiancheng LIU, Y. Zhang, Qin‐Fen Li, Q. Wang, Zhifeng Gu
Topics & Concepts
Protein kinase BPI3K/AKT/mTOR pathwayOvarian cancerViability assayCancer researchMedicineCell growthSignal transductionDownregulation and upregulationmicroRNACancerApoptosisOncologyBiologyCell biologyInternal medicineGeneBiochemistryMicroRNA in disease regulationInflammasome and immune disordersCancer, Stress, Anesthesia, and Immune Response